首页 > 最新文献

Journal of Maternal-Fetal & Neonatal Medicine最新文献

英文 中文
Prenatal radiofrequency ablation for bronchopulmonary sequestration: a case report of successful fetal intervention and longitudinal outcomes. 产前射频消融治疗支气管肺隔离:一例成功的胎儿干预和纵向结果报告。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-03-18 DOI: 10.1080/14767058.2026.2640647
Hui Xi, Huilin Su, Zheming Jiang, GuiJun Li, Yingchun Luo, Yabing Tang, Huiping Zhang, Dandan Ling

Introduction: Bronchopulmonary sequestration (BPS), a rare congenital pulmonary malformation, is characterized by nonfunctional pulmonary parenchyma with aberrant systemic arterial supply (typically from the aorta or its major branches) and absence of communication with the tracheobronchial tree. Large BPS lesions pose significant fetal risks, including hydrops fetalis, mediastinal shift, and polyhydramnios, necessitating timely prenatal intervention to prevent fetal demise.

Case presentation: We present a case of successful ultrasound-guided radiofrequency ablation (RFA) of the feeding artery in a fetus diagnosed with BPS at 22 weeks of gestation. Under ultrasound guidance, a 17-gauge RFA needle was percutaneously inserted into the aberrant feeding artery, achieving complete vascular occlusion without procedural complications. Serial prenatal ultrasounds demonstrated progressive lesion involution. The pregnancy was complicated by cephalopelvic disproportion (CPD), prompting cesarean delivery at 38 weeks. Neonatal computed tomography (CT) confirmed shrinkage of the residual sequestration tissue. Six-month postnatal follow-up revealed normal respiratory function, age-appropriate growth, and developmental milestones.

Conclusion: RFA represents a safe and effective minimally invasive prenatal therapy for BPS. Candidate selection requires comprehensive evaluation of fetal hydrops, lesion size, gestational age, and parental preferences. Amniotic fluid sampling during the procedure is advisable for genetic/ancillary testing. This case highlights the utility of RFA in optimizing fetal outcomes while avoiding open neonatal period surgery. Long-term neonatal follow-up supports the durability of vascular occlusion and functional recovery.

支气管肺隔离(BPS)是一种罕见的先天性肺畸形,其特征是肺实质无功能,全身动脉供应异常(通常来自主动脉或其主要分支),缺乏与气管支气管树的联系。大的BPS病变会造成严重的胎儿风险,包括胎儿水肿、纵隔移位和羊水过多,需要及时的产前干预以防止胎儿死亡。病例介绍:我们报告一例成功的超声引导射频消融术(RFA)喂养动脉的胎儿诊断为BPS在妊娠22周。在超声引导下,17号RFA针经皮插入异常供血动脉,实现血管完全闭塞,无手术并发症。连续产前超声检查显示病变渐进性复旧。妊娠合并头盆腔畸形(CPD),在38周时剖宫产。新生儿计算机断层扫描(CT)证实了残留隔离组织的收缩。6个月后随访显示呼吸功能正常,与年龄相符的生长和发育里程碑。结论:RFA是一种安全有效的产前微创治疗BPS的方法。候选人的选择需要综合评估胎儿水肿,病变大小,胎龄和父母的偏好。建议在手术过程中抽取羊水进行遗传/辅助检测。本病例强调RFA在优化胎儿结局的同时避免开放性新生儿期手术的效用。长期新生儿随访支持血管闭塞的持久性和功能恢复。
{"title":"Prenatal radiofrequency ablation for bronchopulmonary sequestration: a case report of successful fetal intervention and longitudinal outcomes.","authors":"Hui Xi, Huilin Su, Zheming Jiang, GuiJun Li, Yingchun Luo, Yabing Tang, Huiping Zhang, Dandan Ling","doi":"10.1080/14767058.2026.2640647","DOIUrl":"https://doi.org/10.1080/14767058.2026.2640647","url":null,"abstract":"<p><strong>Introduction: </strong>Bronchopulmonary sequestration (BPS), a rare congenital pulmonary malformation, is characterized by nonfunctional pulmonary parenchyma with aberrant systemic arterial supply (typically from the aorta or its major branches) and absence of communication with the tracheobronchial tree. Large BPS lesions pose significant fetal risks, including hydrops fetalis, mediastinal shift, and polyhydramnios, necessitating timely prenatal intervention to prevent fetal demise.</p><p><strong>Case presentation: </strong>We present a case of successful ultrasound-guided radiofrequency ablation (RFA) of the feeding artery in a fetus diagnosed with BPS at 22 weeks of gestation. Under ultrasound guidance, a 17-gauge RFA needle was percutaneously inserted into the aberrant feeding artery, achieving complete vascular occlusion without procedural complications. Serial prenatal ultrasounds demonstrated progressive lesion involution. The pregnancy was complicated by cephalopelvic disproportion (CPD), prompting cesarean delivery at 38 weeks. Neonatal computed tomography (CT) confirmed shrinkage of the residual sequestration tissue. Six-month postnatal follow-up revealed normal respiratory function, age-appropriate growth, and developmental milestones.</p><p><strong>Conclusion: </strong>RFA represents a safe and effective minimally invasive prenatal therapy for BPS. Candidate selection requires comprehensive evaluation of fetal hydrops, lesion size, gestational age, and parental preferences. Amniotic fluid sampling during the procedure is advisable for genetic/ancillary testing. This case highlights the utility of RFA in optimizing fetal outcomes while avoiding open neonatal period surgery. Long-term neonatal follow-up supports the durability of vascular occlusion and functional recovery.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2640647"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147482148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between second-trimester sFlt-1/PlGF ratio and composite adverse neonatal outcome in patients with preeclampsia. 子痫前期妊娠中期sFlt-1/PlGF比值与新生儿综合不良结局的关系
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-03-26 DOI: 10.1080/14767058.2026.2638630
Jie Liu, Nana Yang, Miao Zhang, Suqin Zhang

Objectives: To investigate the predictive performance of the second-trimester soluble fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PlGF) ratio for composite adverse neonatal outcome (CANO) in preeclampsia (PE).

Methods: This retrospective cohort study enrolled 253 PE women during June 2022-June 2024. Maternal serum levels of sFlt-1 and PlGF were assessed, and their ratio was determined at 13-27 gestational weeks. Subjects were stratified into CANO (n = 80) and non-CANO (n = 173) groups. Baseline characteristics and the sFlt-1/PlGF ratio were compared. Univariate and multivariate logistic regression analyses were employed to identify independent risk factors for CANO. Predictive value was assessed using ROC curve analysis, and a nomogram prediction model was constructed.

Results: The sFlt-1/PlGF ratio was markedly higher in the CANO group than the non-CANO group (p < 0.001). Multivariate analysis identified the sFlt-1/PlGF ratio (OR = 1.040, 95% CI: 1.020-1.060, p < 0.001), serum uric acid level (OR = 1.007, 95% CI: 1.000-1.013, p = 0.043), and history of pre-pregnancy hypertension (OR = 13.51, 95% CI: 2.065-88.36, p = 0.007) as independent risk factors for CANO. Conversely, gestational age at delivery (OR = 0.727, 95% CI: 0.621-0.852, p < 0.001) was a protective factor. The sFlt-1/PlGF ratio predicted CANO with an AUC of 0.799 (95% CI: 0.743-0.855). The integrated nomogram model achieved a C-index of 0.880 (95% CI: 0.836-0.923), indicating excellent discrimination.

Conclusion: The second-trimester sFlt-1/PlGF ratio is an independent predictor for CANO in PE. A model incorporating this biomarker facilitates the early identification of high-risk neonates, informing personalized perinatal management.

目的:探讨妊娠中期可溶性膜样酪氨酸激酶-1/胎盘生长因子(sFlt-1/PlGF)比值对子痫前期(PE)复合新生儿不良结局(CANO)的预测作用。方法:这项回顾性队列研究于2022年6月至2024年6月期间招募了253名PE女性。评估母体血清sFlt-1和PlGF水平,并在妊娠13-27周测定其比值。将受试者分为CANO组(n = 80)和非CANO组(n = 173)。比较基线特征和sFlt-1/PlGF比值。采用单因素和多因素logistic回归分析确定CANO的独立危险因素。采用ROC曲线分析评估预测价值,并建立nomogram预测模型。结果:CANO组sFlt-1/PlGF比值明显高于非CANO组(p OR = 1.040, 95% CI: 1.020 ~ 1.060, p OR = 1.007, 95% CI: 1.000 ~ 1.013, p = 0.043),且孕前高血压史(OR = 13.51, 95% CI: 2.065 ~ 88.36, p = 0.007)为CANO的独立危险因素。相反,分娩时胎龄(OR = 0.727, 95% CI: 0.621-0.852, p CI: 0.743-0.855)。综合模态图模型的c指数为0.880 (95% CI: 0.836-0.923),判别性良好。结论:妊娠中期sFlt-1/PlGF比值是PE CANO的独立预测因子。纳入该生物标志物的模型有助于早期识别高危新生儿,为个性化围产期管理提供信息。
{"title":"Association between second-trimester sFlt-1/PlGF ratio and composite adverse neonatal outcome in patients with preeclampsia.","authors":"Jie Liu, Nana Yang, Miao Zhang, Suqin Zhang","doi":"10.1080/14767058.2026.2638630","DOIUrl":"https://doi.org/10.1080/14767058.2026.2638630","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the predictive performance of the second-trimester soluble fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PlGF) ratio for composite adverse neonatal outcome (CANO) in preeclampsia (PE).</p><p><strong>Methods: </strong>This retrospective cohort study enrolled 253 PE women during June 2022-June 2024. Maternal serum levels of sFlt-1 and PlGF were assessed, and their ratio was determined at 13-27 gestational weeks. Subjects were stratified into CANO (<i>n</i> = 80) and non-CANO (<i>n</i> = 173) groups. Baseline characteristics and the sFlt-1/PlGF ratio were compared. Univariate and multivariate logistic regression analyses were employed to identify independent risk factors for CANO. Predictive value was assessed using ROC curve analysis, and a nomogram prediction model was constructed.</p><p><strong>Results: </strong>The sFlt-1/PlGF ratio was markedly higher in the CANO group than the non-CANO group (<i>p</i> < 0.001). Multivariate analysis identified the sFlt-1/PlGF ratio (<i>OR</i> = 1.040, 95% <i>CI</i>: 1.020-1.060, <i>p</i> < 0.001), serum uric acid level (<i>OR</i> = 1.007, 95% <i>CI</i>: 1.000-1.013, <i>p</i> = 0.043), and history of pre-pregnancy hypertension (<i>OR</i> = 13.51, 95% <i>CI</i>: 2.065-88.36, <i>p</i> = 0.007) as independent risk factors for CANO. Conversely, gestational age at delivery (<i>OR</i> = 0.727, 95% <i>CI</i>: 0.621-0.852, <i>p</i> < 0.001) was a protective factor. The sFlt-1/PlGF ratio predicted CANO with an AUC of 0.799 (95% <i>CI</i>: 0.743-0.855). The integrated nomogram model achieved a C-index of 0.880 (95% <i>CI</i>: 0.836-0.923), indicating excellent discrimination.</p><p><strong>Conclusion: </strong>The second-trimester sFlt-1/PlGF ratio is an independent predictor for CANO in PE. A model incorporating this biomarker facilitates the early identification of high-risk neonates, informing personalized perinatal management.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2638630"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147516023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intra-operative fetal monitoring during non-obstetric surgery for complications after bariatric surgery: a standard operating procedure. 减肥手术后并发症的非产科手术中术中胎儿监护:标准操作程序。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-03-05 DOI: 10.1080/14767058.2026.2637209
V Habraken, D A A van der Woude, K Houthoff-Khemlani, W K G Leclercq, H J Niemarkt, J O E H van Laar

Introduction: Pregnancy after bariatric surgery is a high-risk pregnancy. Post-bariatric complications may require emergency surgical intervention. During laparoscopic surgery, anesthetic drugs and formation of pneumoperitoneum influence maternal hemodynamics and may impair the perfusion of the utero-placental unit. Subsequent changes of the fetal heart rate (FHR) might be recognized with intra-operative fetal monitoring and guide maternal positioning and hemodynamic management to maintain fetal wellbeing. However, current fetal monitoring guidelines do not include FHR interpretation during general anesthesia. Furthermore, FHR registration using conventional cardiotocogram (CTG) may be technically difficult due to surgically induced pneumoperitoneum. We developed a multidisciplinary local standard operating procedure based on current literature and guidelines. Intra-operative fetal monitoring using conventional CTG was implemented during laparoscopic surgery for suspected complication after bariatric surgery. We aim to establish whether FHR monitoring during laparoscopy is technically feasible. Secondary, we aim to establish a guideline for interpretation of intra-operative FHR during surgery.

Methods and analysis: Prospective, observational, feasibility study in a tertiary care hospital with a national referral function for post-bariatric complications in pregnancy. We will collect data from pregnant women with a gestational age of ≥ 24 weeks with a suspicion of a complication after bariatric surgery requiring surgical exploration. Non-Dutch speaking women and women with multiple gestation will be excluded. Data will be collected in Research Manager and analyzed using IBM SPSS Statistics for Windows, version 22.

Discussion: The available literature on intra-operative fetal monitoring is scarce. However, despite ambiguity in current international guidelines FHR monitoring is performed in various clinics. To avoid unnecessary caesareans during surgery it is important that FHR monitoring is of sufficient registration quality and that there are guidelines for interpretation of CTG during general anesthesia. However, the technique of intra-operative CTG has not been validated and hence the relevance of our standard operating procedure on intra-operative fetal monitoring during surgery for complications after bariatric surgery.

简介:减肥手术后妊娠是高危妊娠。肥胖后并发症可能需要紧急手术干预。在腹腔镜手术中,麻醉药物和气腹的形成影响母体血流动力学,并可能损害子宫-胎盘单元的灌注。术中胎儿监测可识别胎儿心率(FHR)的变化,指导产妇体位和血流动力学管理,以维持胎儿健康。然而,目前的胎儿监测指南不包括全麻期间FHR的解释。此外,由于手术引起的气腹,使用常规心电图(CTG)登记FHR在技术上可能很困难。我们在现有文献和指南的基础上制定了一个多学科的本地标准操作程序。在腹腔镜手术中使用常规CTG进行术中胎儿监测,以预防减肥手术后的疑似并发症。我们的目的是确定腹腔镜下FHR监测在技术上是否可行。其次,我们的目标是建立一个解释术中FHR的指南。方法与分析:在一家三级医院进行前瞻性、观察性、可行性研究,该医院具有全国转诊功能,用于治疗妊娠后肥胖并发症。我们将收集胎龄≥24周的孕妇的数据,这些孕妇在减肥手术后疑似有并发症,需要手术探查。非荷兰语妇女和多胎妊娠妇女将被排除在外。数据将收集在研究经理和分析使用IBM SPSS统计Windows,版本22。讨论:术中胎儿监护的文献很少。然而,尽管目前的国际指南含糊不清,但在各个诊所进行了FHR监测。为了避免手术中不必要的剖宫产,重要的是FHR监测具有足够的登记质量,并且有解释全麻期间CTG的指南。然而,术中CTG技术尚未得到验证,因此我们的标准操作程序与减肥手术后手术中胎儿监测并发症的相关性。
{"title":"Intra-operative fetal monitoring during non-obstetric surgery for complications after bariatric surgery: a standard operating procedure.","authors":"V Habraken, D A A van der Woude, K Houthoff-Khemlani, W K G Leclercq, H J Niemarkt, J O E H van Laar","doi":"10.1080/14767058.2026.2637209","DOIUrl":"10.1080/14767058.2026.2637209","url":null,"abstract":"<p><strong>Introduction: </strong>Pregnancy after bariatric surgery is a high-risk pregnancy. Post-bariatric complications may require emergency surgical intervention. During laparoscopic surgery, anesthetic drugs and formation of pneumoperitoneum influence maternal hemodynamics and may impair the perfusion of the utero-placental unit. Subsequent changes of the fetal heart rate (FHR) might be recognized with intra-operative fetal monitoring and guide maternal positioning and hemodynamic management to maintain fetal wellbeing. However, current fetal monitoring guidelines do not include FHR interpretation during general anesthesia. Furthermore, FHR registration using conventional cardiotocogram (CTG) may be technically difficult due to surgically induced pneumoperitoneum. We developed a multidisciplinary local standard operating procedure based on current literature and guidelines. Intra-operative fetal monitoring using conventional CTG was implemented during laparoscopic surgery for suspected complication after bariatric surgery. We aim to establish whether FHR monitoring during laparoscopy is technically feasible. Secondary, we aim to establish a guideline for interpretation of intra-operative FHR during surgery.</p><p><strong>Methods and analysis: </strong>Prospective, observational, feasibility study in a tertiary care hospital with a national referral function for post-bariatric complications in pregnancy. We will collect data from pregnant women with a gestational age of ≥ 24 weeks with a suspicion of a complication after bariatric surgery requiring surgical exploration. Non-Dutch speaking women and women with multiple gestation will be excluded. Data will be collected in Research Manager and analyzed using IBM SPSS Statistics for Windows, version 22.</p><p><strong>Discussion: </strong>The available literature on intra-operative fetal monitoring is scarce. However, despite ambiguity in current international guidelines FHR monitoring is performed in various clinics. To avoid unnecessary caesareans during surgery it is important that FHR monitoring is of sufficient registration quality and that there are guidelines for interpretation of CTG during general anesthesia. However, the technique of intra-operative CTG has not been validated and hence the relevance of our standard operating procedure on intra-operative fetal monitoring during surgery for complications after bariatric surgery.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2637209"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147366889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A prospective study on maternal and neonatal outcomes and influencing factors in pregnant women with borderline hypertension. 边缘性高血压孕妇母婴结局及影响因素的前瞻性研究
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-01-15 DOI: 10.1080/14767058.2026.2614186
Wenmei Chen, Xiaotong Tang, Lizhou Sun, Dan Wu, Yuanyuan Zhang

Objective: To investigate maternal and neonatal outcomes and influencing factors in pregnant women with borderline hypertension.

Methods: This prospective cohort study consecutively enrolled 600 pregnant women receiving prenatal care at two hospitals between January 1 and December 31, 2024. Participants were divided into a normotensive control group (n = 300) and a borderline hypertension group (systolic 130-139 mmHg and/or diastolic 80-89 mmHg, n = 300). The primary outcome was progression to hypertensive disorders of pregnancy (HDP). Maternal and neonatal outcomes were compared, and influencing factors were analyzed.

Results: Women with borderline hypertension exhibited significantly higher rates of cesarean delivery (63.0% vs. 42.0%; p < 0.001), HDP progression (27.0% vs. 0.0%; p < 0.001), fetal growth restriction (15.7% vs. 2.7%; p < 0.001), and NICU admission (13.7% vs. 4.0%; p < 0.001) compared to normotensive controls. Notably, later gestational age at onset of borderline hypertension was identified as a protective factor against HDP progression (OR = 0.785 per week; 95% CI: 0.724-0.851; p < 0.001), corresponding to a 21.5% risk reduction for each delayed week of onset.

Conclusion: Borderline hypertension is associated with markedly increased adverse perinatal outcomes. Early detection and intervention-especially for women developing borderline elevation before 20 weeks-may help mitigate HDP progression. Integrating blood pressure trajectory monitoring into routine prenatal care is recommended.

目的:探讨交界性高血压孕妇的母婴结局及影响因素。方法:本前瞻性队列研究纳入了2024年1月1日至12月31日在两家医院接受产前护理的600名孕妇。参与者被分为正常血压对照组(n = 300)和临界高血压组(收缩压130- 139mmhg和/或舒张压80- 89mmhg, n = 300)。主要结局是进展为妊娠期高血压疾病(HDP)。比较产妇和新生儿的结局,并分析影响因素。结果:交界性高血压妇女的剖宫产率显著增高(63.0% vs 42.0%); p p p p p结论:交界性高血压与围产期不良结局显著增加相关。早期发现和干预,特别是对20周前出现边缘性增高的妇女,可能有助于缓解HDP的进展。建议将血压轨迹监测纳入常规产前护理。
{"title":"A prospective study on maternal and neonatal outcomes and influencing factors in pregnant women with borderline hypertension.","authors":"Wenmei Chen, Xiaotong Tang, Lizhou Sun, Dan Wu, Yuanyuan Zhang","doi":"10.1080/14767058.2026.2614186","DOIUrl":"https://doi.org/10.1080/14767058.2026.2614186","url":null,"abstract":"<p><strong>Objective: </strong>To investigate maternal and neonatal outcomes and influencing factors in pregnant women with borderline hypertension.</p><p><strong>Methods: </strong>This prospective cohort study consecutively enrolled 600 pregnant women receiving prenatal care at two hospitals between January 1 and December 31, 2024. Participants were divided into a normotensive control group (<i>n</i> = 300) and a borderline hypertension group (systolic 130-139 mmHg and/or diastolic 80-89 mmHg, <i>n</i> = 300). The primary outcome was progression to hypertensive disorders of pregnancy (HDP). Maternal and neonatal outcomes were compared, and influencing factors were analyzed.</p><p><strong>Results: </strong>Women with borderline hypertension exhibited significantly higher rates of cesarean delivery (63.0% vs. 42.0%; <i>p</i> < 0.001), HDP progression (27.0% vs. 0.0%; <i>p</i> < 0.001), fetal growth restriction (15.7% vs. 2.7%; <i>p</i> < 0.001), and NICU admission (13.7% vs. 4.0%; <i>p</i> < 0.001) compared to normotensive controls. Notably, later gestational age at onset of borderline hypertension was identified as a protective factor against HDP progression (OR = 0.785 per week; 95% CI: 0.724-0.851; <i>p</i> < 0.001), corresponding to a 21.5% risk reduction for each delayed week of onset.</p><p><strong>Conclusion: </strong>Borderline hypertension is associated with markedly increased adverse perinatal outcomes. Early detection and intervention-especially for women developing borderline elevation before 20 weeks-may help mitigate HDP progression. Integrating blood pressure trajectory monitoring into routine prenatal care is recommended.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2614186"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statement of Retraction: Low-dose vaginal misoprostol in the management of intrauterine fetal death. 撤回声明:低剂量阴道米索前列醇在处理宫内胎儿死亡中的作用。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-01-21 DOI: 10.1080/14767058.2026.2617534
{"title":"Statement of Retraction: Low-dose vaginal misoprostol in the management of intrauterine fetal death.","authors":"","doi":"10.1080/14767058.2026.2617534","DOIUrl":"https://doi.org/10.1080/14767058.2026.2617534","url":null,"abstract":"","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2617534"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-level laser therapy for breastfeeding women with nipple pain in the early postpartum period: a randomized controlled trial. 低水平激光治疗产后早期乳头疼痛的母乳喂养妇女:一项随机对照试验。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-02-25 DOI: 10.1080/14767058.2026.2636360
Maria Vc Gaitero, Ticiana Aa Mira, Edna Jl Gondim, Andrea V Gonçalves, Simony L Nascimento, Fernanda G Surita

Background: During the immediate postpartum period, breastfeeding could be challenge for many women due nipple pain and trauma. Non-pharmacological therapeutic strategies that reduce pain and accelerate healing are essential to prevent early weaning and support successful lactation.

Objective: This study aimed to evaluate the effectiveness of low-level laser therapy (LLLT) in reducing pain and promoting healing of nipple trauma in postpartum women, as well as to assess participants satisfaction with the intervention.

Methods: This multicentric, controlled, randomized, double-blind clinical trial included 60 women equally divided into an experimental group (2 J of red light at the nipple's central point and 4 J of infrared light in a cross pattern over the areolar region) and a sham group. Pain intensity was measured using the Numeric Rating Scale before, during, and up to 7 days after the intervention, and healing was assessed using a validated instrument. Intention-to-treat analysis was conducted.

Results: We found a significant reduction in pain in the experimental group, with relief observed 30 min (p = 0.0439) after the LLLT application. Pain diary analyses indicated that, compared to the sham group, the experimental group reported lower pain intensity at 1h (p = 0.0485), 6h (p = 0.0194), 12h (p = 0.0033), and 7 days after the intervention (p = 0.0085). There was no significant difference in the level of satisfaction between groups (p = 0.652), and no adverse effects were identified.

Conclusion: LLLT proved to be a safe, effective, and feasible approach for managing pain associated with nipple trauma in the early postpartum, providing maternal comfort and supporting the continuation of exclusive breastfeeding.

背景:在紧接的产后时期,由于乳头疼痛和创伤,母乳喂养对许多妇女来说可能是一个挑战。减轻疼痛和加速愈合的非药物治疗策略对于防止早期断奶和支持成功哺乳至关重要。目的:本研究旨在评价低水平激光治疗(LLLT)对产后妇女乳头创伤的缓解疼痛和促进愈合的效果,并评估参与者对干预的满意度。方法:这项多中心、对照、随机、双盲临床试验包括60名妇女,平均分为实验组(乳头中心点红光照射2 J,乳晕区交叉红外光照射4 J)和假手术组。在干预前、干预期间和干预后7天内使用数值评定量表测量疼痛强度,并使用经过验证的仪器评估愈合情况。进行意向治疗分析。结果:我们发现实验组疼痛明显减轻,在应用LLLT后30分钟(p = 0.0439)有所缓解。疼痛日记分析显示,与假手术组相比,实验组在干预后1小时(p = 0.0485)、6小时(p = 0.0194)、12小时(p = 0.0033)和7天(p = 0.0085)的疼痛强度较低。两组患者满意度差异无统计学意义(p = 0.652),未发现不良反应。结论:在产后早期处理乳头外伤相关疼痛时,LLLT被证明是一种安全、有效和可行的方法,可以提供母亲舒适,并支持纯母乳喂养的继续。
{"title":"Low-level laser therapy for breastfeeding women with nipple pain in the early postpartum period: a randomized controlled trial.","authors":"Maria Vc Gaitero, Ticiana Aa Mira, Edna Jl Gondim, Andrea V Gonçalves, Simony L Nascimento, Fernanda G Surita","doi":"10.1080/14767058.2026.2636360","DOIUrl":"https://doi.org/10.1080/14767058.2026.2636360","url":null,"abstract":"<p><strong>Background: </strong>During the immediate postpartum period, breastfeeding could be challenge for many women due nipple pain and trauma. Non-pharmacological therapeutic strategies that reduce pain and accelerate healing are essential to prevent early weaning and support successful lactation.</p><p><strong>Objective: </strong>This study aimed to evaluate the effectiveness of low-level laser therapy (LLLT) in reducing pain and promoting healing of nipple trauma in postpartum women, as well as to assess participants satisfaction with the intervention.</p><p><strong>Methods: </strong>This multicentric, controlled, randomized, double-blind clinical trial included 60 women equally divided into an experimental group (2 J of red light at the nipple's central point and 4 J of infrared light in a cross pattern over the areolar region) and a sham group. Pain intensity was measured using the Numeric Rating Scale before, during, and up to 7 days after the intervention, and healing was assessed using a validated instrument. Intention-to-treat analysis was conducted.</p><p><strong>Results: </strong>We found a significant reduction in pain in the experimental group, with relief observed 30 min (<i>p</i> = 0.0439) after the LLLT application. Pain diary analyses indicated that, compared to the sham group, the experimental group reported lower pain intensity at 1h (<i>p</i> = 0.0485), 6h (<i>p</i> = 0.0194), 12h (<i>p</i> = 0.0033), and 7 days after the intervention (<i>p</i> = 0.0085). There was no significant difference in the level of satisfaction between groups (<i>p</i> = 0.652), and no adverse effects were identified.</p><p><strong>Conclusion: </strong>LLLT proved to be a safe, effective, and feasible approach for managing pain associated with nipple trauma in the early postpartum, providing maternal comfort and supporting the continuation of exclusive breastfeeding.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2636360"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147311984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological considerations in evaluating intrapartum hyoscine butyl bromide for delayed labor progress. 评价产时丁溴海辛延缓产程的方法学考虑。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-01-14 DOI: 10.1080/14767058.2026.2612842
Ankur Sharma, Sushma Narsing Katkuri, Varshini Vadhithala, Arun Kumar, Sushma Verma, Dhanya Dedeepya
{"title":"Methodological considerations in evaluating intrapartum hyoscine butyl bromide for delayed labor progress.","authors":"Ankur Sharma, Sushma Narsing Katkuri, Varshini Vadhithala, Arun Kumar, Sushma Verma, Dhanya Dedeepya","doi":"10.1080/14767058.2026.2612842","DOIUrl":"https://doi.org/10.1080/14767058.2026.2612842","url":null,"abstract":"","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2612842"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of physiological interpretation of fetal heart rate changes: from scientific principles to frontline practice. 胎儿心率变化生理解读的实施:从科学原理到一线实践。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-01-14 DOI: 10.1080/14767058.2025.2612451
Edwin Chandraharan, Ilenia Mappa, Anna Gracia Perez-Bonfils, Susana Pereira

Onset of uterine contractions which become progressively more frequent, intense and last for longer durations as the labor progresses is expected to cause a gradually evolving hypoxic stress to human fetuses. This is because of the repeated constriction of maternal spiral arterioles supplying the placental bed and compression of the umbilical cord as the labor advances. The majority of fetuses are able to mount physiological compensatory responses to protect their high priority central organs by maintaining aerobic metabolism. However, fetuses who are exposed to preexisting compromise such as chronic utero-placental insufficiency, chorioamnionitis or chronic fetal anemia and acidosis may not have sufficient reserves to withstand further hypoxic stress, leading to rapid decompensation and neurological injury or death. Physiological interpretation of fetal heart rate changes involves recognition of specific features of both hypoxic and non-hypoxic stresses on the cardiotocograph (CTG) and determining the fetal compensatory responses to ongoing stress. This approach which is based on the cardinal principle of individualization of care will enable frontline clinicians to differentiate features of compensation from decompensation. Timely interventions to improve intrauterine environment and/or to accomplish urgent birth will help avoid hypoxic ischemic encephalopathy (HIE) and its long term sequalae (cerebral palsy or learning difficulties) and perinatal deaths. Conversely, continuation of labor with careful observation in fetuses with compensated gradually evolving hypoxic stress will help avoid unnecessary intrapartum operative interventions. Emerging evidence suggests reduction in the rates of both HIE and emergency cesarean sections following the implementation of principles of physiological interpretation of CTG.

随着分娩的进行,子宫收缩逐渐变得更频繁,更强烈,持续时间更长,预计会对人类胎儿造成逐渐演变的缺氧应激。这是由于分娩过程中供给胎盘床的母体螺旋小动脉反复收缩和脐带受压所致。大多数胎儿能够通过维持有氧代谢来建立生理代偿反应,以保护其高优先级的中枢器官。然而,暴露于慢性子宫胎盘功能不全、绒毛膜羊膜炎或慢性胎儿贫血和酸中毒等先前存在的损害的胎儿可能没有足够的储备来承受进一步的缺氧应激,导致快速失代偿和神经损伤或死亡。胎儿心率变化的生理解释包括识别心脏造影(CTG)上缺氧和非缺氧应激的特定特征,并确定胎儿对持续应激的代偿反应。这种基于个性化护理基本原则的方法将使一线临床医生能够区分补偿和失代偿的特征。及时干预改善宫内环境和/或完成紧急分娩将有助于避免缺氧缺血性脑病(HIE)及其长期后遗症(脑瘫或学习困难)和围产期死亡。相反,对于代偿性逐渐发展的低氧应激胎儿,继续分娩并仔细观察将有助于避免不必要的产时手术干预。新出现的证据表明,实施CTG的生理解释原则后,HIE和紧急剖宫产的发生率均有所降低。
{"title":"Implementation of physiological interpretation of fetal heart rate changes: from scientific principles to frontline practice.","authors":"Edwin Chandraharan, Ilenia Mappa, Anna Gracia Perez-Bonfils, Susana Pereira","doi":"10.1080/14767058.2025.2612451","DOIUrl":"https://doi.org/10.1080/14767058.2025.2612451","url":null,"abstract":"<p><p>Onset of uterine contractions which become progressively more frequent, intense and last for longer durations as the labor progresses is expected to cause a gradually evolving hypoxic stress to human fetuses. This is because of the repeated constriction of maternal spiral arterioles supplying the placental bed and compression of the umbilical cord as the labor advances. The majority of fetuses are able to mount physiological compensatory responses to protect their high priority central organs by maintaining aerobic metabolism. However, fetuses who are exposed to preexisting compromise such as chronic utero-placental insufficiency, chorioamnionitis or chronic fetal anemia and acidosis may not have sufficient reserves to withstand further hypoxic stress, leading to rapid decompensation and neurological injury or death. Physiological interpretation of fetal heart rate changes involves recognition of specific features of both hypoxic and non-hypoxic stresses on the cardiotocograph (CTG) and determining the fetal compensatory responses to ongoing stress. This approach which is based on the cardinal principle of individualization of care will enable frontline clinicians to differentiate features of compensation from decompensation. Timely interventions to improve intrauterine environment and/or to accomplish urgent birth will help avoid hypoxic ischemic encephalopathy (HIE) and its long term sequalae (cerebral palsy or learning difficulties) and perinatal deaths. Conversely, continuation of labor with careful observation in fetuses with compensated gradually evolving hypoxic stress will help avoid unnecessary intrapartum operative interventions. Emerging evidence suggests reduction in the rates of both HIE and emergency cesarean sections following the implementation of principles of physiological interpretation of CTG.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2612451"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transient conductive hearing loss as a notable and rare manifestation of preeclampsia: a case report. 一过性传导性听力损失是子痫前期一个显著而罕见的表现:1例报告。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-01-25 DOI: 10.1080/14767058.2026.2616104
Xiuying Chen, Linna Jin, Baihui Zhao
<p><strong>Objective: </strong>To report a case of transient conductive hearing loss secondary to secretory otitis media (SOM) in a patient with preeclampsia, highlight its unique pathophysiological link, and emphasize the importance of recognizing this potential complication.</p><p><strong>Case presentation: </strong>Preeclampsia is a severe, pregnancy-specific multisystem disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. While endothelial dysfunction and vasospasm are central to its pathophysiology, its clinical manifestations are diverse. Auditory dysfunction, particularly conductive hearing loss, is infrequently reported. We present a case of a 25-year-old gravida 2, para 0 woman diagnosed with preeclampsia at 33 weeks of gestation. She had persistent proteinuria (24-hour urinary protein 1244.7 mg), unstable hypertension (148-165/95-107mmHg) managed with labetalol (100 mg every 8 h, suboptimal adherence), and gestational diabetes. She had no prior history of ear disease, trauma, or ototoxic medication use.At 35w5d gestation, the patient developed sudden bilateral hearing loss, accompanied by mild chest tightness and an elevated brain natriuretic peptide (BNP) level (346.1 pg/ml). Otolaryngology consultation was performed, and otoendoscopic examination revealed bilateral intratympanic fluid. Pure tone audiometry confirmed bilateral conductive hearing loss with significant air-bone gaps (left 30 dB, right 13 dB). Bone conduction thresholds were within normal limits (left 15 dB, right 16 dB), ruling out sensorineural hearing loss. Acoustic immittance audiometry showed bilateral B-type tympanograms, indicative of middle ear effusion. Alternative causes of conductive hearing loss (e.g. upper respiratory infection-related eustachian tube dysfunction, barotrauma, tympanic membrane pathology, middle ear mass) were excluded through clinical evaluation, negative inflammatory markers (C-reactive protein: <0.5 mg/l, white blood cell count: 12.9 × 10^9), and absence of relevant symptoms. Given her deteriorating condition, an emergent Cesarean section was performed at 36 weeks of gestation, delivering a healthy male infant. Postoperatively, supportive management with combined diuretics (furosemide and spironolactone) led to rapid and complete resolution of her hearing deficits within three days. She was discharged on continued antihypertensive therapy and was well at one-month follow-up.</p><p><strong>Conclusion: </strong>Transient conductive hearing loss due to SOM is a rare manifestation of preeclampsia, likely driven by hypertension-induced increased vascular permeability and altered fluid dynamics. Severe proteinuria may exacerbate systemic fluid imbalance, contributing to middle ear effusion. Early recognition <i>via</i> audiometric and tympanometric evaluation, exclusion of alternative etiologies, and targeted management (e.g. fluid overload reduction) can ensure prompt recovery and improve maternal outcome
目的:报告1例子痫前期患者继发于分泌性中耳炎(SOM)的一过性传导性听力损失,强调其独特的病理生理联系,并强调认识这一潜在并发症的重要性。病例介绍:子痫前期是一种严重的妊娠特异性多系统疾病,以妊娠20周后新发高血压和蛋白尿为特征。虽然内皮功能障碍和血管痉挛是其病理生理的核心,但其临床表现是多种多样的。听力障碍,特别是传导性听力损失,很少被报道。我们提出一个25岁的孕妇2,第0段妇女诊断为先兆子痫在妊娠33周。她有持续性蛋白尿(24小时尿蛋白1244.7 mg),不稳定高血压(148-165/95-107mmHg),拉贝他洛尔治疗(每8小时100 mg,依从性不佳)和妊娠糖尿病。患者既往无耳部疾病、外伤或耳毒性药物使用史。妊娠35w5d时,患者出现突发性双侧听力丧失,伴有轻度胸闷和脑钠肽(BNP)水平升高(346.1 pg/ml)。耳鼻喉科会诊,耳内窥镜检查发现双侧鼓室内积液。纯音测听证实双侧传导性听力损失,伴有明显的气骨间隙(左侧30 dB,右侧13 dB)。骨传导阈值在正常范围内(左15 dB,右16 dB),排除感音神经性听力损失。声学阻抗测听显示双侧b型鼓室图,提示中耳积液。通过临床评估排除传导性听力损失的其他原因(如上呼吸道感染相关的咽鼓管功能障碍、气压损伤、鼓膜病理、中耳肿块),炎症标志物(c反应蛋白)阴性。结论:SOM引起的短暂性传导性听力损失是子痫前期的一种罕见表现,可能由高血压引起的血管通透性增加和流体动力学改变引起。严重的蛋白尿可加重全身体液失衡,导致中耳积液。通过听力和鼓室测量评估进行早期识别,排除其他病因,并进行有针对性的管理(例如减少液体过载),可以确保迅速恢复并改善产妇结局。早期识别和管理可以通过解决体液失调和潜在的预防进一步并发症来改善产妇结局。
{"title":"Transient conductive hearing loss as a notable and rare manifestation of preeclampsia: a case report.","authors":"Xiuying Chen, Linna Jin, Baihui Zhao","doi":"10.1080/14767058.2026.2616104","DOIUrl":"https://doi.org/10.1080/14767058.2026.2616104","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To report a case of transient conductive hearing loss secondary to secretory otitis media (SOM) in a patient with preeclampsia, highlight its unique pathophysiological link, and emphasize the importance of recognizing this potential complication.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Case presentation: &lt;/strong&gt;Preeclampsia is a severe, pregnancy-specific multisystem disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. While endothelial dysfunction and vasospasm are central to its pathophysiology, its clinical manifestations are diverse. Auditory dysfunction, particularly conductive hearing loss, is infrequently reported. We present a case of a 25-year-old gravida 2, para 0 woman diagnosed with preeclampsia at 33 weeks of gestation. She had persistent proteinuria (24-hour urinary protein 1244.7 mg), unstable hypertension (148-165/95-107mmHg) managed with labetalol (100 mg every 8 h, suboptimal adherence), and gestational diabetes. She had no prior history of ear disease, trauma, or ototoxic medication use.At 35w5d gestation, the patient developed sudden bilateral hearing loss, accompanied by mild chest tightness and an elevated brain natriuretic peptide (BNP) level (346.1 pg/ml). Otolaryngology consultation was performed, and otoendoscopic examination revealed bilateral intratympanic fluid. Pure tone audiometry confirmed bilateral conductive hearing loss with significant air-bone gaps (left 30 dB, right 13 dB). Bone conduction thresholds were within normal limits (left 15 dB, right 16 dB), ruling out sensorineural hearing loss. Acoustic immittance audiometry showed bilateral B-type tympanograms, indicative of middle ear effusion. Alternative causes of conductive hearing loss (e.g. upper respiratory infection-related eustachian tube dysfunction, barotrauma, tympanic membrane pathology, middle ear mass) were excluded through clinical evaluation, negative inflammatory markers (C-reactive protein: &lt;0.5 mg/l, white blood cell count: 12.9 × 10^9), and absence of relevant symptoms. Given her deteriorating condition, an emergent Cesarean section was performed at 36 weeks of gestation, delivering a healthy male infant. Postoperatively, supportive management with combined diuretics (furosemide and spironolactone) led to rapid and complete resolution of her hearing deficits within three days. She was discharged on continued antihypertensive therapy and was well at one-month follow-up.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Transient conductive hearing loss due to SOM is a rare manifestation of preeclampsia, likely driven by hypertension-induced increased vascular permeability and altered fluid dynamics. Severe proteinuria may exacerbate systemic fluid imbalance, contributing to middle ear effusion. Early recognition &lt;i&gt;via&lt;/i&gt; audiometric and tympanometric evaluation, exclusion of alternative etiologies, and targeted management (e.g. fluid overload reduction) can ensure prompt recovery and improve maternal outcome","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2616104"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146047291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introduction of central fetal monitoring and impact on neonatal outcome - a retrospective observational cohort study. 引入中心胎儿监护及其对新生儿结局的影响——一项回顾性观察队列研究。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-01 Epub Date: 2026-02-15 DOI: 10.1080/14767058.2026.2629687
Maria Söröd, Erika Gyllencreutz

Introduction: Cardiotocography (CTG) is used for fetal surveillance to prevent asphyxia related neonatal outcomes during pregnancy and delivery. In Sweden, all delivery wards have transitioned from CTG registered and printed on paper inside the delivery room, to digital central fetal monitoring where CTG is visible both in the delivery room and on distance for multiple observers. We aimed to evaluate whether the transition from CTG on paper to central fetal monitoring has affected neonatal morbidity.

Material and methods: The study was conducted as a retrospective cohort study. Data from 8577 deliveries in Östersund, Sweden were extracted from medical records. The study population was divided into two cohorts, one where the CTG registration during delivery had been printed on paper (Cohort I, January 2012-December 2015), and one where digital central fetal monitoring was used (Cohort II, July 2016-December 2019). The cohorts were compared regarding the incidence of neonatal metabolic acidosis (umbilical artery pH <7.05 and base deficit >12 mmol/L) as the main outcome, and secondary outcomes such as Apgar score at 5 min of age, the incidence of neonatal resuscitation, and the incidence of emergency cesarean and instrumental vaginal birth due to suspected fetal hypoxia.

Results: The incidence of metabolic acidosis was 0.5% in Cohort I and 0.6% in Cohort II, odds ratio (OR) 1.27, 95% confidence interval (CI) 0.67-2.40, p = 0.46. There were no statistically significant differences in any of the secondary neonatal outcomes. Adjustment for potential confounders did not alter the estimates. The cohorts differed in the incidence of inductions of labor; 18.8% in Cohort I vs 23.2% in Cohort II, p < 0.0001, and the use of oxytocin; 50.2% vs 60.0%, p < 0.0001, both of which were more frequent in Cohort II. The incidence of instrumental vaginal births due to suspected fetal hypoxia was lower in the cohort with digital CTG; 3.6% vs 2.6%, p = 0.01.

Conclusion: We observed no difference regarding the incidence of neonatal metabolic acidosis or other neonatal outcomes between the cohort that had CTG registered and printed on paper, and the cohort with digital central fetal monitoring.

心脏造影(CTG)用于胎儿监测,以防止在怀孕和分娩期间窒息相关的新生儿结局。在瑞典,所有产房都已从CTG登记并打印在产房内的纸上,过渡到数字中心胎儿监测,在产房内和多个观察者都可以看到CTG。我们的目的是评估从纸面CTG到中心胎儿监测的转变是否影响了新生儿的发病率。材料和方法:本研究采用回顾性队列研究。从医疗记录中提取瑞典Östersund的8577例分娩数据。研究人群分为两组,一组使用纸质打印分娩期间CTG登记(队列1,2012年1月至2015年12月),另一组使用数字中心胎儿监测(队列2,2016年7月至2019年12月)。比较两组以新生儿代谢性酸中毒发生率(脐动脉pH为12 mmol/L)为主要结局,以及5 min时Apgar评分、新生儿复苏发生率、疑似胎儿缺氧导致的紧急剖宫产和顺产发生率等次要结局。结果:队列1代谢性酸中毒发生率为0.5%,队列2为0.6%,优势比(OR) 1.27, 95%可信区间(CI) 0.67 ~ 2.40, p = 0.46。在新生儿的继发性结局方面没有统计学上的显著差异。对潜在混杂因素的调整没有改变估计。两组在引产发生率上存在差异;队列I为18.8%,队列II为23.2%,p p p = 0.01。结论:我们观察到,在新生儿代谢性酸中毒的发生率和其他新生儿结局方面,CTG登记并打印在纸上的队列与数字中心胎儿监测队列没有差异。
{"title":"Introduction of central fetal monitoring and impact on neonatal outcome - a retrospective observational cohort study.","authors":"Maria Söröd, Erika Gyllencreutz","doi":"10.1080/14767058.2026.2629687","DOIUrl":"https://doi.org/10.1080/14767058.2026.2629687","url":null,"abstract":"<p><strong>Introduction: </strong>Cardiotocography (CTG) is used for fetal surveillance to prevent asphyxia related neonatal outcomes during pregnancy and delivery. In Sweden, all delivery wards have transitioned from CTG registered and printed on paper inside the delivery room, to digital central fetal monitoring where CTG is visible both in the delivery room and on distance for multiple observers. We aimed to evaluate whether the transition from CTG on paper to central fetal monitoring has affected neonatal morbidity.</p><p><strong>Material and methods: </strong>The study was conducted as a retrospective cohort study. Data from 8577 deliveries in Östersund, Sweden were extracted from medical records. The study population was divided into two cohorts, one where the CTG registration during delivery had been printed on paper (Cohort I, January 2012-December 2015), and one where digital central fetal monitoring was used (Cohort II, July 2016-December 2019). The cohorts were compared regarding the incidence of neonatal metabolic acidosis (umbilical artery pH <7.05 and base deficit >12 mmol/L) as the main outcome, and secondary outcomes such as Apgar score at 5 min of age, the incidence of neonatal resuscitation, and the incidence of emergency cesarean and instrumental vaginal birth due to suspected fetal hypoxia.</p><p><strong>Results: </strong>The incidence of metabolic acidosis was 0.5% in Cohort I and 0.6% in Cohort II, odds ratio (OR) 1.27, 95% confidence interval (CI) 0.67-2.40, <i>p</i> = 0.46. There were no statistically significant differences in any of the secondary neonatal outcomes. Adjustment for potential confounders did not alter the estimates. The cohorts differed in the incidence of inductions of labor; 18.8% in Cohort I vs 23.2% in Cohort II, <i>p</i> < 0.0001, and the use of oxytocin; 50.2% vs 60.0%, <i>p</i> < 0.0001, both of which were more frequent in Cohort II. The incidence of instrumental vaginal births due to suspected fetal hypoxia was lower in the cohort with digital CTG; 3.6% vs 2.6%, <i>p</i> = 0.01.</p><p><strong>Conclusion: </strong>We observed no difference regarding the incidence of neonatal metabolic acidosis or other neonatal outcomes between the cohort that had CTG registered and printed on paper, and the cohort with digital central fetal monitoring.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2629687"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146203602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Maternal-Fetal & Neonatal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1